Tad Coffin Performance Saddles, Inc. – Trademark Portfolio
Entity Type: 03
Tad Coffin Performance Saddles, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TC, SMART RIDE, THERA-TREE, SMARTRIDE RX, and SR SMART RIDE (INSIDE). The owner is based in Ruckersville, VA.
1151 Dairy Road
Ruckersville, VA 22968
Showing of trademarks Trademarks
Trademark Classifications
Tad Coffin Performance Saddles, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Tad Coffin Performance Saddles, Inc. have?
Tad Coffin Performance Saddles, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Tad Coffin Performance Saddles, Inc. file in?
Tad Coffin Performance Saddles, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 10 (Medical Apparatus). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are Tad Coffin Performance Saddles, Inc.'s most well-known trademarks?
Tad Coffin Performance Saddles, Inc.'s registered trademark portfolio includes well-known marks such as TC, SMART RIDE, THERA-TREE, SMARTRIDE RX, and SR SMART RIDE (INSIDE). These are among 6 currently registered trademarks in the portfolio.
What is Tad Coffin Performance Saddles, Inc.'s trademark registration success rate?
Tad Coffin Performance Saddles, Inc. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.